Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing
- PMID: 35304093
- PMCID: PMC8923710
- DOI: 10.1016/j.cca.2022.03.014
Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing
Abstract
Introduction: Genomic surveillance of the SARS-CoV-2 virus is important to assess transmissibility, disease severity, and vaccine effectiveness. The SARS-CoV-2 genome consists of approximately 30 kb single-stranded RNA that is too large to analyze the whole genome by Sanger sequencing. Thus, in this study, we performed Sanger sequencing following long-range RT-PCR of the entire SARS-CoV-2 S-gene and analyzed the mutational dynamics.
Methods: The 4 kb region, including the S-gene, was amplified by two-step long-range RT-PCR. Then, the entire S-gene sequence was determined by Sanger sequencing. The amino acid mutations were identified as compared with the reference SARS-CoV-2 genome.
Results: The S:D614G mutation was found in all samples. The R.1 variants were detected after January 2021. Alpha variants started to emerge in April 2021. Delta variants replaced Alpha in July 2021. Then, Omicron variants were detected after December 2021. These mutational dynamics in samples collected in the Chiba University Hospital were similar to those in Japan.
Conclusion: The emergence of variants of concern (VOC) has been reported by the entire S-gene analysis. As the VOCs have unique mutational patterns of the S-gene region, analysis of the entire S-gene will be useful for molecular surveillance of the SARS-CoV-2 in clinical laboratories.
Keywords: Long-range RT-PCR; S-gene; SARS-CoV-2; Sanger sequencing; Surveillance.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196812 Free PMC article.
-
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.Microbiol Spectr. 2022 Feb 23;10(1):e0143821. doi: 10.1128/spectrum.01438-21. Epub 2022 Jan 5. Microbiol Spectr. 2022. PMID: 34985323 Free PMC article.
-
Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.Adv Clin Chem. 2024;118:35-85. doi: 10.1016/bs.acc.2023.11.003. Epub 2023 Dec 14. Adv Clin Chem. 2024. PMID: 38280807 Review.
-
Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.Viruses. 2023 Feb 21;15(3):593. doi: 10.3390/v15030593. Viruses. 2023. PMID: 36992302 Free PMC article.
-
Mosaic Recombination Inflicted Various SARS-CoV-2 Lineages to Emerge into Novel Virus Variants: a Review Update.Indian J Clin Biochem. 2022 Dec 17;38(4):1-8. doi: 10.1007/s12291-022-01109-w. Online ahead of print. Indian J Clin Biochem. 2022. PMID: 36569378 Free PMC article. Review.
Cited by
-
An Update on Detection Technologies for SARS-CoV-2 Variants of Concern.Viruses. 2022 Oct 22;14(11):2324. doi: 10.3390/v14112324. Viruses. 2022. PMID: 36366421 Free PMC article. Review.
-
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon.Heliyon. 2024 Apr 6;10(7):e29243. doi: 10.1016/j.heliyon.2024.e29243. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38623229 Free PMC article.
-
"Nano COVID-19": Nanopore sequencing of spike gene to identify SARS-CoV-2 variants of concern.Exp Biol Med (Maywood). 2023 Oct;248(20):1841-1849. doi: 10.1177/15353702231190931. Epub 2023 Sep 13. Exp Biol Med (Maywood). 2023. PMID: 37702217 Free PMC article.
-
In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2023 Jan;95(1):e28213. doi: 10.1002/jmv.28213. Epub 2022 Oct 17. J Med Virol. 2023. PMID: 36224626 Free PMC article. No abstract available.
-
Two-Stage Mixed-Dye-Based Isothermal Amplification with Ribonuclease-Cleavable Enhanced Probes for Dual-Visualization Detection of SARS-CoV-2 Variants of Interest.Adv Sci (Weinh). 2024 Aug;11(29):e2401988. doi: 10.1002/advs.202401988. Epub 2024 Jun 3. Adv Sci (Weinh). 2024. PMID: 38829265 Free PMC article.
References
-
- World Health Organization (WHO), WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int, 2021 (accessed 16 December 2021).
-
- Volz E., Mishra S., Chand M., Barrett J.C., Johnson R., Geidelberg L., Hinsley W.R., Laydon D.J., Dabrera G., O’Toole Á., Amato R., Ragonnet-Cronin M., Harrison I., Jackson B., Ariani C.V., Boyd O., Loman N.J., McCrone J.T., Gonçalves S., Jorgensen D., Myers R., Hill V., Jackson D.K., Gaythorpe K., Groves N., Sillitoe J., Kwiatkowski D.P., Flaxman S., Ratmann O., Bhatt S., Hopkins S., Gandy A., Rambaut A., Ferguson N.M. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 2021;593(7858):266–269. - PubMed
-
- Singh J., Rahman S.A., Ehtesham N.Z., Hira S., Hasnain S.E. SARS-CoV-2 variants of concern are emerging in India. Nat. Med. 2021;27:1131–1133. - PubMed
-
- Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Pérez Marc G., Moreira E.D., Zerbini C., Bailey R., Swanson K.A., Roychoudhury S., Koury K., Li P., Kalina W.V., Cooper D., Frenck R.W., Jr, Hammitt L.L., Türeci Ö., Nell H., Schaefer A., Ünal S., Tresnan D.B., Mather S., Dormitzer P.R., Şahin U., Jansen K.U., Gruber W.C. C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 2020;383:2603–2615. - PMC - PubMed
-
- Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., McGettigan J., Khetan S., Segall N., Solis J., Brosz A., Fierro C., Schwartz H., Neuzil K., Corey L., Gilbert P., Janes H., Follmann D., Marovich M., Mascola J., Polakowski L., Ledgerwood J., Graham B.S., Bennett H., Pajon R., Knightly C., Leav B., Deng W., Zhou H., Han S., Ivarsson M., Miller J., Zaks T., COVE Study Group Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403–416. - PMC - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous